Corrected Ca²⁺ (mmol/L) = Total Ca²⁺ + [0.02 × (40 − albumin in g/L)] ^[1][2][3]

• The logic: for every 4 g/L drop in albumin below 40 g/L, total calcium drops by about 0.1 mmol/L (purely because there is less protein to bind calcium, not because ionized calcium has changed).
• This formula does NOT work reliably when albumin < 20 g/L, or in the presence of multiple myeloma / dysglobulinemia — in these cases, you must directly measure ionized Ca²⁺ ^[1][3].

• Hypocalcemia is common in hospitalized patients, especially in ICU settings (up to 80–90% of ICU patients have low ionized calcium).
• In the outpatient/community setting, the commonest causes are:
  • Vitamin D deficiency — extremely common in institutionalized patients (elderly in care homes), those with limited sun exposure, dark skin, and poor dietary intake ^[2]
  • Post-surgical hypoparathyroidism — the single most common cause of hypoparathyroidism worldwide; after thyroidectomy, parathyroidectomy, or radical neck dissection ^[2][3]
• In Hong Kong specifically:
  • Vitamin D deficiency is surprisingly common despite the subtropical latitude, due to indoor lifestyles, sunscreen use, and limited dietary vitamin D (traditional Chinese diet is not fortified with vitamin D unlike Western diets)
  • Post-thyroidectomy hypocalcemia is a significant issue given the relatively high prevalence of thyroid nodules and multinodular goitre requiring surgery
  • Chronic kidney disease (CKD) is prevalent (diabetes and hypertension as leading causes) → secondary hyperparathyroidism with hypocalcemia

• Bone: 99% (stored as hydroxyapatite crystals — Ca₁₀(PO₄)₆(OH)₂) ^[1]
• Muscle: 0.3% ^[1]
• Extracellular fluid: 0.1% ^[1]
• The tiny fraction in ECF is tightly regulated because it is critical for neuromuscular function, coagulation, enzyme activity, and cell signalling.

The four parathyroid glands sit on the posterior surface of the thyroid. They are small (3–5 mm), easily damaged or devascularized during thyroid surgery. The inferior parathyroids are more variable in position (embryologically derived from the 3rd pharyngeal pouch — they migrate further during development) and thus more at risk during surgery.

Post-surgical hypoparathyroidism is very common; doesn't even have to be a complete thyroidectomy to cause issues ^[2] — even a subtotal thyroidectomy or central neck dissection can damage the parathyroid glands or their blood supply. This can be:

• Transient (due to temporary vascular compromise or oedema → "vascular" cause per VINDICATE mnemonic ^[3]) — resolves in days to weeks
• Permanent (if glands are inadvertently removed or permanently devascularized)

Once genuine hypocalcemia is confirmed, the causes can be organized by mechanism:

• Pseudohypoparathyroidism: post-receptor defect in PTH signalling ^[2]
• PTH is high (parathyroids are working hard) but end-organs (kidney, bone) do not respond
• Type 1a (Albright hereditary osteodystrophy): short stature, round face, short 4th/5th metacarpals, subcutaneous calcifications, intellectual disability
• Biochemistry: low Ca²⁺, high PO₄³⁻, high PTH (mimics hypoparathyroidism biochemically but PTH is elevated, not low)

Magnesium deficiency causes hypocalcemia through two mechanisms ^[2][4]:

1. Impaired PTH secretion — Mg²⁺ is required for PTH release from parathyroid glands; severe hypomagnesemia (Mg < 0.4 mmol/L) blocks PTH exocytosis
2. PTH resistance — Mg²⁺ is needed for PTH receptor signalling in target organs

Low magnesium inhibits PTH action → causing hypokalemia and hypocalcemia ^[4]. This is a classic triad: hypomagnesemia + hypocalcemia + hypokalemia. The hypocalcemia will NOT respond to calcium replacement alone — you must correct the magnesium first.

Causes of hypomagnesemia: chronic alcoholism, PPIs, loop/thiazide diuretics, aminoglycosides, cisplatin, chronic diarrhoea.

• Acute illness / sepsis (multifactorial: cytokine effects, vitamin D pathway dysfunction, chelation)
• Fluoride poisoning (calcium fluoride is insoluble → chelation)

This is the key concept to understand for clinical features.

Calcium plays a critical role in stabilizing voltage-gated sodium channels on cell membranes. Specifically:

1. Normal calcium: Ca²⁺ ions sit on the extracellular surface of the sodium channel, raising the threshold for channel activation. This means a bigger depolarization is needed to open the channel → the membrane is "stable."

2. Low calcium: With fewer Ca²⁺ ions stabilizing the channels, the threshold for sodium channel activation drops. Now, smaller stimuli can trigger an action potential → the nerve/muscle is hyperexcitable.

3. This leads to spontaneous firing of motor and sensory nerves → tetany, paraesthesia, muscle spasms, and ultimately seizures.

Think of calcium as a "brake" on nerve excitability. Remove the brake (hypocalcemia), and everything fires too easily.

• Ca²⁺ is essential for the plateau phase (Phase 2) of the cardiac action potential — it enters through L-type calcium channels and sustains depolarization.
• Low calcium → prolonged Phase 2 → prolonged QT interval on ECG
• Severe hypocalcemia → reduced myocardial contractility → hypotension, heart failure
• Can predispose to torsades de pointes (polymorphic ventricular tachycardia) if QT is sufficiently prolonged

A useful pathophysiological framework:

1. PTH deficiency (Hypoparathyroidism) — surgical, autoimmune, infiltrative, genetic
2. PTH resistance (Pseudohypoparathyroidism)
3. Vitamin D deficiency/resistance — dietary, malabsorption, hepatic, renal, genetic
4. Calcium sequestration/redistribution — pancreatitis, rhabdomyolysis, massive transfusion, hungry bone, TLS
5. Magnesium depletion — impaired PTH secretion + resistance
6. Drug-induced

• Acute hypocalcemia — develops over hours to days; more likely to be symptomatic and dangerous (neuromuscular irritability, cardiac arrhythmia, laryngeal spasm, seizures)
• Chronic hypocalcemia — develops slowly; compensatory mechanisms allow tolerance of lower levels; may present with more insidious features (cataracts, basal ganglia calcification, dental abnormalities, neuropsychiatric symptoms)

The classic picture of hypoparathyroidism: low calcium, high-normal or high phosphate, low PTH ^[3]. The high phosphate occurs because PTH normally promotes renal phosphate excretion — without PTH, phosphate is retained.

• When adjusted serum calcium falls below 1.9 mmol/L, although this threshold varies ^[2][3]
• Above 2.0 mmol/L, more than half of patients will be asymptomatic ^[2]
• Also depends on the rate of fall of serum calcium — with quicker falls there is less time for compensation to occur ^[2]
  • Example: A patient whose calcium drops from 2.4 to 1.8 over 2 hours (e.g. post-thyroidectomy) will be much more symptomatic than a CKD patient whose calcium has been 1.8 for months

• Alkalosis worsens hypocalcemia symptoms (even without changing total calcium) because:

  • In alkalosis, H⁺ concentration falls
  • H⁺ normally competes with Ca²⁺ for binding to albumin
  • With fewer H⁺, more Ca²⁺ binds to albumin → ionized Ca²⁺ drops
  • This is why hyperventilating patients (respiratory alkalosis) develop perioral tingling and carpopedal spasm

• Acidosis protects against hypocalcemia symptoms because:

  • More H⁺ displaces Ca²⁺ from albumin → ionized Ca²⁺ rises
  • This is clinically relevant: correcting acidosis (e.g. with bicarbonate) in a patient with borderline calcium can unmask symptomatic hypocalcemia

• In hypoparathyroidism and CKD, phosphate is elevated — this worsens hypocalcemia by:
  1. Direct complexation: Ca²⁺ + PO₄³⁻ → calcium phosphate precipitates
  2. Suppression of 1α-hydroxylase activity (high PO₄³⁻ inhibits the enzyme)
  3. The calcium × phosphate product: if > 4.4 (mmol²/L²), risk of metastatic calcification (soft tissue calcium phosphate deposition)

• You might think low calcium means less calcification, but the opposite occurs
• Chronic low Ca²⁺ and high PO₄³⁻ (especially in hypoparathyroidism) → the Ca × PO₄ product may still be elevated locally in brain tissue
• Altered local tissue pH and cellular damage → dystrophic calcification
• The basal ganglia have a rich blood supply and are particularly susceptible

These share the biochemical pattern: ↓Ca²⁺, ↓ or normal PO₄³⁻, ↑PTH (secondary hyperparathyroidism). The elevated PTH drives phosphaturia, so phosphate is low or normal (unlike hypoparathyroidism where PO₄ is high).

In these conditions, PTH is appropriately elevated (the parathyroids are trying to compensate), but calcium is being consumed, deposited, or chelated faster than PTH can mobilize it.

• Hypocalcemia is extremely common (up to 80–90%) and usually multifactorial
• Causes: sepsis (cytokine-mediated), massive transfusion (citrate), renal impairment, medications (loop diuretics, aminoglycosides), alkalosis, hypoalbuminemia
• Always check ionized calcium in ICU — total calcium is unreliable in critical illness (multiple confounders: low albumin, acid-base shifts, citrate)

Screening electrolytes should include Ca, P, Mg, ALP, and ferritin after diagnosis of CPPD disease ^[11] — because CPPD can be secondary to metabolic conditions including hyperparathyroidism (and thus also occurs in patients who develop hypocalcemia after parathyroidectomy for hyperparathyroidism).

These are the investigations you order simultaneously when genuine hypocalcemia is confirmed. The logic is to quickly categorize the cause.

Vitamin D measurement interpretation ^[15]:

• 25(OH)D reflects level of intake and production — if Low → nutritional insufficiency
• 1,25(OH)₂D reflects level of active hormone — if High/normal → Type II vitamin D-dependent rickets (receptor defect); if Low → Type I vitamin D-dependent rickets (1α-hydroxylase deficiency, amenable to calcitriol replacement)

Routinely check Ca level on post-op Day 1 ^[16] after parathyroidectomy. Watch for:

• Hungry bone syndrome: rapid, profound hypocalcaemia due to sudden drop in PTH, causing rapid deposition of Ca into demineralized bone ^[16]
• After focused parathyroidectomy: transient suppression of normal glands by adenoma ^[16]
• Permanent hypoparathyroidism: requiring Ca/vitamin D supplement 1 year post-op ^[16]

Monitor serum calcium level closely (e.g. q6–8h) ^[3] during IV calcium gluconate infusion. The aim is low normal range for calcium ^[3] — you do NOT need to normalize calcium completely, just bring it into a safe range to prevent life-threatening complications (seizures, laryngeal spasm, arrhythmia).

ECG and cardiac monitoring ^[3] must be initiated immediately because:

• Hypocalcemia prolongs QT → risk of torsades de pointes
• IV calcium replacement itself can cause arrhythmia if given too rapidly
• You need a baseline ECG and continuous monitoring throughout treatment

IV calcium gluconate by infusion ^[3][2]:

Initial bolus:

• 10% calcium gluconate 20 ml IV over 10–15 minutes ^[3][2]
  • 10% calcium gluconate = 0.22 mmol elemental Ca²⁺ per mL
  • 20 mL = 4.4 mmol (≈180 mg) elemental calcium
  • Must be given slowly (over 10–15 min, not pushed as a fast bolus) — rapid infusion can cause bradycardia, hypotension, or cardiac arrest

Maintenance infusion:

• 30 ml 10% calcium gluconate in 500 ml NS or D5 Q4–6H per pint ^[3]
  • This provides a continuous, steady supply of calcium while you work on oral replacement
  • Adjust rate based on repeat calcium levels

Monitor serum calcium level closely (e.g. q6–8h) ^[3]

• The effect of IV calcium is transient (half-life of infused calcium is minutes to hours) — it redistributes quickly
• Frequent monitoring ensures you are achieving target and not overshooting (hypercalcemia from over-replacement can cause its own arrhythmias)

Prescribe oral calcium as well — dual pronged approach ^[3]

• Start oral calcium supplements alongside IV therapy so that by the time IV is weaned, oral therapy is already on board
• This bridges the transition from acute parenteral to chronic oral management

Aim for low normal range for calcium ^[3] — you do NOT need to normalize calcium completely. The goal is:

• Get calcium above 2.0 mmol/L ^[2] — this eliminates the risk of life-threatening complications
• Overly aggressive correction (pushing calcium to high-normal or above) is unnecessary and risks hypercalcemia-related complications

Oral replacement of calcium ^[2]:

• Typical starting dose: 1–2 g elemental calcium per day in divided doses (e.g. Caltrate 600 mg BD–TDS)
• Take with meals to improve absorption (gastric acid enhances calcium salt dissolution)
• Avoid taking with iron supplements or high-fibre meals (reduce absorption)

Vitamin D / calcitriol — consider adding if no response after 2–4 g elemental calcium ^[2]

The choice of vitamin D preparation depends on the underlying cause:

• Acute (post-op): IV calcium gluconate as above + oral calcium + calcitriol
• Transient (days–weeks): Often resolves as parathyroid glands recover from vascular compromise/oedema. Wean supplements gradually while monitoring Ca levels.
• Permanent hypoparathyroidism: requiring Ca/vitamin D supplement 1 year post-op ^[16] — defined as persistent need for calcium/calcitriol > 6–12 months after surgery
  • Long-term: oral calcium (1–3 g elemental calcium/day) + calcitriol (0.25–2 µg/day)
  • Monitor calcium and phosphate regularly; aim for low-normal calcium to avoid hypercalciuria and renal stones
  • Recombinant PTH (rhPTH 1-84 / teriparatide): Now approved in some jurisdictions for chronic hypoparathyroidism refractory to conventional therapy. Allows reduction in calcium/calcitriol doses and reduces hypercalciuria. Not first-line.

• Rapid, profound hypocalcaemia due to sudden drop in PTH, causing rapid deposition of Ca into demineralized bone ^[16]
• Management: Ca + vitamin D ^[16]
• May require prolonged high-dose IV calcium (sometimes days to weeks) with aggressive oral supplementation
• Also replete magnesium and phosphate (both are consumed by hungry bone)

Low magnesium inhibits PTH action → hypokalemia and hypocalcemia ^[4]

• Correct magnesium FIRST — hypocalcemia will NOT respond to calcium replacement alone until Mg is corrected
• IV magnesium sulphate (MgSO₄): 2 g (8 mmol) IV over 15–30 min, then maintenance infusion (e.g. 4–6 g over 24h)
• Also give oral magnesium for ongoing repletion
• Once Mg is corrected, PTH secretion and action normalizes → calcium spontaneously improves
• Simultaneously correct hypokalemia (K replacement)

• Also supplement oral calcium (1–1.5 g elemental calcium/day)
• Monitor 25(OH)D levels at 3 months to confirm repletion

This is a complex, multi-pronged management strategy per KDOQI guidelines ^[17]:

Treatment of CKD-MBD: ^[17]

Essential to replace calcium with 10% calcium gluconate (10 ml Ca gluconate for every 1 litre of citrated blood transfused) ^[8]

• This is prophylactic — give calcium alongside transfusion
• Monitor ionized calcium during massive transfusion
• Also use blood warmers to prevent hypothermia (compounds coagulopathy)

• Treat the underlying condition as the primary intervention
• Replace calcium as needed (usually IV gluconate for symptomatic cases)
• In rhabdomyolysis, be cautious with calcium replacement in the early phase — calcium can deposit in damaged muscle, worsening injury. Replace only if symptomatic or severely low.
• Once the acute phase resolves, sequestered calcium is released back → can develop rebound hypercalcemia in recovery phase of rhabdomyolysis

• Prevention is key — recognize high-risk patients before chemotherapy
• Aggressive hydration: 3 L/m²/day ^[18]
• Correction of hyperkalemia + ECG monitoring ^[18]
• Hypocalcemia in TLS: do NOT aggressively replace calcium unless symptomatic — giving calcium in the setting of high phosphate will precipitate calcium-phosphate in tissues (metastatic calcification, nephrocalcinosis)
• Focus on lowering phosphate first (hydration, rasburicase for urate, phosphate binders if needed)
• RRT if necessary ^[18]

• Review and stop/adjust offending medications where possible
• Bisphosphonate/denosumab-induced: ensure vitamin D is replete before starting these drugs; supplement calcium
• Cisplatin-induced: replace magnesium (cisplatin causes renal Mg wasting) → calcium will follow
• Cinacalcet-induced: dose reduction or discontinuation

Laryngeal spasm ^[2][3] — this is the most feared acute complication and a medical emergency.

• Mechanism: The recurrent laryngeal nerve (a branch of the vagus nerve, CN X) innervates most intrinsic muscles of the larynx. When extracellular Ca²⁺ is critically low, the nerve becomes hyperexcitable and fires spontaneously → the laryngeal muscles contract involuntarily → the vocal cords adduct (close) → the airway is obstructed.
• Presentation: Stridor (high-pitched inspiratory sound), acute dyspnoea, inability to speak, cyanosis. The patient literally cannot breathe.
• Why it kills: Complete obstruction → no ventilation → hypoxia → cardiac arrest within minutes if untreated.
• Management: Immediate IV calcium gluconate to relax the spasm; may need emergency intubation or cricothyrotomy if airway cannot be secured.

Act quick to prevent further complications ^[2] — this is the clinical imperative. Any patient with symptomatic hypocalcemia must be treated urgently before laryngeal spasm or seizures develop.

The infamous QMH case: Patient suddenly couldn't breathe due to hypocalcemia-induced laryngeal spasm → almost died during colonoscopy ^[6] (following oral phospho-soda bowel preparation causing acute phosphate nephropathy → severe hypocalcemia).

Convulsion ^[2][3]

• Mechanism: CNS neuronal hyperexcitability — voltage-gated sodium channels are destabilized (fewer Ca²⁺ ions holding them in the closed state) → lowered seizure threshold → spontaneous neuronal firing → generalized tonic-clonic seizures.
• Key point: Hypocalcemic seizures may be the presenting feature, especially in neonates and young children (e.g. DiGeorge syndrome presenting with neonatal seizures). In adults, seizures usually indicate severe hypocalcemia (Ca < 1.5 mmol/L).
• Danger: Seizures can cause aspiration, head injury, rhabdomyolysis (which further worsens hypocalcemia through calcium sequestration in muscle — a vicious cycle), and status epilepticus.
• Management: IV calcium gluconate is the primary treatment — standard anticonvulsants (benzodiazepines, phenytoin) may not be fully effective until calcium is corrected. Note: phenytoin itself accelerates vitamin D catabolism and can worsen hypocalcemia chronically.

Arrhythmia ^[8][20]

• Mechanism: Calcium is essential for Phase 2 (plateau) of the cardiac action potential. Low Ca²⁺ → prolonged Phase 2 → prolonged QT interval → risk of torsades de pointes (polymorphic ventricular tachycardia) → can degenerate into ventricular fibrillation → cardiac arrest.
• Also: Reduced myocardial contractility → hypotension → haemodynamic compromise → heart failure in severe cases.
• Citrate toxicity in massive transfusion: citrate chelates calcium, lowers ionized calcium level, leading to QT prolongation and arrhythmia ^[8]
• Management: IV calcium gluconate + continuous cardiac monitoring. Correct hypocalcemia before attempting other anti-arrhythmic therapy.

The prolonged QT from hypocalcemia is specifically a prolongation of the ST segment (Phase 2) — distinct from hypokalemia, which prolongs QT via T wave flattening and U wave prominence. This ECG distinction is exam-relevant.

Tetany ^[3] (from Greek "tetanos" = to stretch)

• Mechanism: Motor neuron hyperexcitability → involuntary, sustained, painful muscle contraction. Affects the hands and feet first (carpopedal spasm: wrist flexion, MCP flexion, IP extension, thumb adduction — "main d'accoucheur"), but can become generalized.
• Complication if untreated: Respiratory muscle spasm → respiratory failure; intercostal and diaphragmatic muscle involvement can compromise ventilation.
• Note: Tetany ≠ tetanus ^[3] — tetany is hypocalcemia-induced muscle spasm from nerve hyperexcitability; tetanus is Clostridium tetani toxin blocking inhibitory interneurons (Renshaw cells) in the spinal cord. Both cause muscle rigidity, but via completely different mechanisms.

• Mechanism: Ca²⁺ is required for excitation-contraction coupling in both cardiac and vascular smooth muscle. Severe hypocalcemia → reduced cardiac contractility (negative inotropic effect) + peripheral vasodilation → hypotension → cardiovascular collapse in extreme cases.
• Can compound other causes of shock (e.g. in pancreatitis, sepsis, massive transfusion).

• Mechanism: Paradoxically, chronic hypocalcemia (especially in hypoparathyroidism with concurrent hyperphosphatemia) leads to dystrophic calcification in the basal ganglia. The elevated calcium × phosphate product locally, combined with altered tissue pH and cellular damage over time, promotes calcium-phosphate crystal deposition.
• Imaging: Bilateral, symmetric calcifications in the basal ganglia, dentate nuclei, and sometimes cortex on CT brain.
• Clinical consequence: Extrapyramidal symptoms — parkinsonism (rigidity, bradykinesia, resting tremor), dystonia, chorea. Also cognitive decline, dementia, psychiatric symptoms.
• Fahr syndrome (or Fahr disease) refers to extensive bilateral basal ganglia calcification; when secondary to hypoparathyroidism, it is technically "Fahr syndrome" (secondary), not Fahr disease (primary/idiopathic).

• Cataracts — specifically posterior subcapsular cataracts
• Mechanism: The lens depends on Ca²⁺ homeostasis for transparency. Chronic low Ca²⁺ → altered lens fiber metabolism → oxidative stress → protein aggregation → opacification. Typically posterior subcapsular type.
• Clinical relevance: May develop in patients with chronic hypoparathyroidism; screening with slit-lamp examination recommended.
• Reversibility: Once formed, cataracts are NOT reversible with calcium correction — requires surgical removal (phacoemulsification).

• Mechanism: Enamel is predominantly hydroxyapatite (calcium phosphate); chronic hypocalcemia during tooth development → enamel hypoplasia, pitting, delayed eruption, root malformation.
• Important in congenital hypoparathyroidism (DiGeorge syndrome) and childhood-onset vitamin D deficiency.

• Mental retardation (in congenital/childhood-onset chronic hypocalcemia) — chronic Ca²⁺ deficit during brain development impairs normal neurodevelopment.
• Mental state affected first in chronic hypocalcemia ^[3] — patients become "less smart than before" ^[3]; insidious cognitive decline, poor concentration, impaired memory.
• Depression, anxiety, psychosis — all described in chronic hypoparathyroidism.
• Pseudotumor cerebri (raised intracranial pressure, papilloedema) — rare but recognized.

• Dry skin, eczematous dermatitis, brittle nails, coarse hair — all ectodermal effects of chronic calcium depletion.
• Chronic mucocutaneous candidiasis in APS-1 (autoimmune polyendocrinopathy) — while not directly from hypocalcemia, it accompanies the hypoparathyroidism.

Hypoparathyroidism leading to hypocalcemia is the MOST common complication of thyroidectomy ^[1][20][21].

Complications of thyroidectomy include ^[21]:

• Primary hypothyroidism requiring lifelong thyroxine replacement
• Vocal cord dysfunction (transient vs. permanent) — recurrent laryngeal nerve injury → hoarseness, dyspnoea if bilateral
• Hypoparathyroidism (transient vs. permanent)
• Bleeding — reactionary haemorrhage → haematoma → airway compression
• Tracheomalacia
• Wound complications (seroma, hypertrophic scar)
• Precipitation of thyroid storm

Pre-operative monitoring of Ca and vitamin D levels and supplementing accordingly is recommended to reduce the severity of post-operative hypocalcemia ^[22].

In the context of CKD, chronic hypocalcemia (and the compensatory secondary hyperparathyroidism) leads to: